Jove
Visualize
Contact Us

Related Experiment Videos

Cancer cachexia: its correlations and causes.

Harry Rubin1

  • 1Department of Molecular and Cell Biology, Life Sciences Addition, University of California, Berkeley, CA 94720-3200, USA. hrubin@uclink4.berkeley.edu

Proceedings of the National Academy of Sciences of the United States of America
|April 19, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Deprivation of glutamine in cell culture reveals its potential for treating cancer.

Proceedings of the National Academy of Sciences of the United States of America·2019
Same author

Phenotypic selection as the biological mode of epigenetic conversion and reversion in cell transformation.

Proceedings of the National Academy of Sciences of the United States of America·2018
Same author

Dynamics of cell transformation in culture and its significance for tumor development in animals.

Proceedings of the National Academy of Sciences of the United States of America·2017
Same author

The paradox of the contrasting roles of chronic magnesium deficiency in metabolic disorders and field cancerization.

Magnesium research·2015
Same author

Promotion and selection by serum growth factors drive field cancerization, which is anticipated in vivo by type 2 diabetes and obesity.

Proceedings of the National Academy of Sciences of the United States of America·2013
Same author

The early history of tumor virology: Rous, RIF, and RAV.

Proceedings of the National Academy of Sciences of the United States of America·2011
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Cancer cachexia, a significant cause of cancer mortality, is driven by peptides released from tumors. These proteolytically generated peptides, not anorexia, cause significant weight loss and systemic effects in cancer patients.

Area of Science:

  • Oncology
  • Biochemistry
  • Molecular Biology

Background:

  • Cancer cachexia is a complex syndrome characterized by significant weight loss, primarily of skeletal muscle and adipose tissue, and is a major contributor to cancer morbidity and mortality.
  • Historically, research focused on toxohormones (peptides from tumors) and later on cytokines and ectopic hormones, but the role of proteases gained attention due to their involvement in neoplastic development.

Purpose of the Study:

  • To re-evaluate the evidence for the role of proteolytically generated peptides from tumors in the development of cancer cachexia.
  • To connect the historical findings on toxohormones with contemporary understanding of protease activity in cancer progression.

Main Methods:

  • Review and re-evaluation of existing studies on tumor-derived peptides (toxohormones) and their effects on cachexia.

Related Experiment Videos

  • Analysis of research on pericellular proteases and protease inhibitors in cancer cell transformation, including experiments with chicken embryo fibroblasts (CEF) infected with Rous sarcoma virus.
  • Correlation of tumor transformation with the release of low molecular weight cytotoxic substances.

    • Main Results:

    • Early studies identified tumor-derived peptides (toxohormones) that induced cachexia-like symptoms in animal models.
    • Protease inhibitors, particularly those in fetal bovine serum, suppressed neoplastic transformation in CEF cells.
    • Extensive Rous sarcoma virus infection of CEF correlated with the release of cytotoxic substances, suggesting a role for proteolysis.

    Conclusions:

    • Proteolytically generated peptides derived from tumors play a central role in causing cancer cachexia.
    • The findings support a unified view where tumor proteases generate peptides that drive the systemic effects of cancer cachexia.
    • This re-evaluation highlights the clinical significance of tumor-derived peptides in cancer progression and patient outcomes.